JP Patent

JP2022528727A — 酸化ストレスに関連する疾患の治療に使用するためのニタゾキサニド及びチアゾリド

Assigned to Genfit SA · Expires 2022-06-15 · 4y expired

What this patent protects

本発明は、ニタゾキサニド、又はその類似体の新規使用に関する。

USPTO Abstract

本発明は、ニタゾキサニド、又はその類似体の新規使用に関する。

Drugs covered by this patent

Patent Metadata

Patent number
JP2022528727A
Jurisdiction
JP
Classification
—
Expires
2022-06-15
Drug substance claim
No
Drug product claim
No
Assignee
Genfit SA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.